128 / 1084
Oesophageal Adenocarcinoma
CROSS Study Comparison
MAGIC
1
- 2006
Periop. chemo
(n=503)
FNCLCC
2
- 2011
Periop. chemo
(n=224)
OE-2
3
- 2009
Pre-op. chemo
(n=802)
CROSS
4
- 2015
Chemorad.
(n=275)
ECF SURG CF SURG CF SURG RCTx SURG
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick
HR=0.75
(95% CI 0.60; 0.93)
HR=0.69
(95% CI 0.50; 0.96)
HR=0.84
(95% CI, 0.72; 0.98)
HR=0.73
(95% CI 0.55; 0.98)
CI: Confidence Interval; CF: Cisplatin, 5-FU; ECF: Epirubicine, Cisplatin, 5-FU; RCTx:
Chemoradiation, SURG: Surgery
4
Shapiro J et al.,
Lancet Oncol
2015
3
Allum B et al.,
J Clin Oncol
2009
2
Ychou M et al.,
J Clin Oncol
2011
1
Cunningham D et al.,
NEJM
2006